The technology which led to the cervical cancer vaccines we know today, Gardasil™ and Cervarix™, was first developed and patented in 1991 by University of Queensland professor Ian Frazer and Dr Jian Zhou in collaboration with researchers from international universities and the National Cancer Institute.
The vaccines are effective against four types of Human Papilloma Virus (HPV) and genital warts, and are enormously effective. They protect against 2 types of HPV which cause 75% of cervical cancer cases, and 2 types which cause 90% of genital warts cases.
More than 100 million doses of these vaccines have now been administered around the world, and Professor Frazer hopes that a great number more will be administered in developing nations, where medical treatment and pap smears are not readily available.
In addition, Professor Frazer’s appointment as chief executive of the Translational Research Institute (TRI), an Australian institute dedicated to taking medical breakthroughs from research and trial to manufacture, bodes well for the future of Australian innovation and medical research.
[img source] J.K. Califf (CCA2.0) bit.ly/1vW49nN